Cargando…

Cytoplasmic IGF2BP2 Protein Expression in Human Patients with Oral Squamous Cell Carcinoma: Prognostic and Clinical Implications

Oral squamous cell carcinoma (OSCC) is particularly prevalent in Taiwan. The goal of this study was to determine the clinicopathological role of insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2) proteins as an indicator of clinical outcomes in OSCC patients. In this study, immunohistoche...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Shu-Hui, Lin, Chiao-Wen, Lu, Jeng-Wei, Yang, Wei-En, Lin, Yueh-Min, Lu, Hsueh-Ju, Yang, Shun-Fa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339407/ https://www.ncbi.nlm.nih.gov/pubmed/35919812 http://dx.doi.org/10.7150/ijms.74751

Ejemplares similares

Decreased Cytoplasmic Expression of ADAMTS14 Is Correlated with Reduced Survival Rates in Oral Squamous Cell Carcinoma Patients
por: Lin, Yueh-Min, et al.
Publicado: (2020)

IGF2BP2 Polymorphisms Are Associated with Clinical Characteristics and Development of Oral Cancer
por: Chou, Chia-Hsuan, et al.
Publicado: (2020)

Prognostic Significance of Cytoplasmic SPNS2 Expression in Patients with Oral Squamous Cell Carcinoma
por: Lu, Jeng-Wei, et al.
Publicado: (2021)

Oral submucous fibrosis stimulates invasion and epithelial‐mesenchymal transition in oral squamous cell carcinoma by activating MMP‐2 and IGF‐IR
por: Chen, Pei‐Ni, et al.
Publicado: (2021)

IGF2BP2 maybe a novel prognostic biomarker in oral squamous cell carcinoma
por: Wang, Xiangpu, et al.
Publicado: (2022)

Identification of IGF2BP3 as an Adverse Prognostic Biomarker of Gliomas
por: Sun, Chao, et al.
Publicado: (2021)

Targeting IGF2BP3 in Cancer
por: Liu, Xin, et al.
Publicado: (2023)

Role of IGF2BP3 in trophoblast cell invasion and migration
por: Li, W, et al.
Publicado: (2014)

Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1) Is a Prognostic Biomarker and Associated with Chemotherapy Responsiveness in Colorectal Cancer
por: Chen, Hung-Ming, et al.
Publicado: (2021)

IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated Liposarcoma
por: Klingbeil, Kyle D., et al.
Publicado: (2023)

Cathepsin B Expression and the Correlation with Clinical Aspects of Oral Squamous Cell Carcinoma
por: Yang, Wei-En, et al.
Publicado: (2016)

Identification of an IGF2BP2-Targeted Peptide for Near-Infrared Imaging of Esophageal Squamous Cell Carcinoma
por: Shu, Wenbin, et al.
Publicado: (2022)

Associations among IGF-1, IGF2, IGF-1R, IGF-2R, IGFBP-3, insulin genetic polymorphisms and central precocious puberty in girls
por: Chang, Hua-Pin, et al.
Publicado: (2018)

Overexpression of IGF2BP3 as a Potential Oncogene in Ovarian Clear Cell Carcinoma
por: Liu, Huidi, et al.
Publicado: (2020)

Mini Review: Molecular Interpretation of the IGF/IGF-1R Axis in Cancer Treatment and Stem Cells-Based Therapy in Regenerative Medicine
por: Lin, Syuan-Ling, et al.
Publicado: (2022)

LCAT1 is an oncogenic LncRNA by stabilizing the IGF2BP2-CDC6 axis
por: Yang, Juze, et al.
Publicado: (2022)

IGF2BP2 promotes head and neck squamous carcinoma cell proliferation and growth via the miR-98-5p/PI3K/Akt signaling pathway
por: Yu, Dan, et al.
Publicado: (2023)

N(6)-methyladenosine reader IGF2BP3 as a prognostic Biomarker contribute to malignant progression of glioma
por: Zheng, Xin, et al.
Publicado: (2023)

Identification of the function and mechanism of m6A reader IGF2BP2 in Alzheimer’s disease
por: Deng, Yanyao, et al.
Publicado: (2021)

High Level of Plasma EGFL6 Is Associated with Clinicopathological Characteristics in Patients with Oral Squamous Cell Carcinoma
por: Chuang, Chun-Yi, et al.
Publicado: (2017)

Curcumin analog HO‐3867 triggers apoptotic pathways through activating JNK1/2 signalling in human oral squamous cell carcinoma cells
por: Chen, Chi‐Wei, et al.
Publicado: (2022)

Circular RNA circIGF2BP3 Promotes the Proliferation and Differentiation of Chicken Primary Myoblasts
por: Wang, Xiaotong, et al.
Publicado: (2023)

IGF2BP2-modified circular RNA circARHGAP12 promotes cervical cancer progression by interacting m(6)A/FOXM1 manner
por: Ji, Fei, et al.
Publicado: (2021)

IGF2BP2 and obesity interaction analysis for type 2 diabetes mellitus in Chinese Han population
por: Wu, Hui-Hui, et al.
Publicado: (2014)

Recognition of RNA N(6)-methyladenosine by IGF2BP Proteins Enhances mRNA Stability and Translation
por: Huang, Huilin, et al.
Publicado: (2018)

IGF2BP2 promotes cancer progression by degrading the RNA transcript encoding a v-ATPase subunit
por: Latifkar, Arash, et al.
Publicado: (2022)

IGF2BP2 regulates DANCR by serving as an N6-methyladenosine reader
por: Hu, Xiaoge, et al.
Publicado: (2019)

TMEM44-AS1 promotes esophageal squamous cell carcinoma progression by regulating the IGF2BP2-GPX4 axis in modulating ferroptosis
por: Yang, Ruotong, et al.
Publicado: (2023)

Expression of the cancer testis antigen IGF2BP3 in colorectal cancers; IGF2BP3 holds promise as a specific immunotherapy target
por: Shantha Kumara, HMC, et al.
Publicado: (2015)

PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer
por: Shi, Yunxing, et al.
Publicado: (2023)

Clinical Significance of an m6A Reader Gene, IGF2BP2, in Head and Neck Squamous Cell Carcinoma
por: Deng, Xiaoli, et al.
Publicado: (2020)

IGF2BP2 serves as a core m6A regulator in head and neck squamous cell carcinoma
por: Hu, Yuan, et al.
Publicado: (2022)

Igf2bp3 maintains maternal RNA stability and ensures early embryo development in zebrafish
por: Ren, Fan, et al.
Publicado: (2020)

Investigation of Igf-1, Igf-Bp3 and Igf-Bp5 levels in umbilical cord blood of infants with developmental dysplasia of the hip
por: DEMİREL, Esra, et al.
Publicado: (2023)

IGF2BP3-induced activation of EIF5B contributes to progression of hepatocellular carcinoma cells
por: LI, XIAOYIN, et al.
Publicado: (2023)

LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer
por: Wang, Yun, et al.
Publicado: (2019)

IGF2BP2 promotes colorectal cancer progression by upregulating the expression of TFRC and enhancing iron metabolism
por: Liu, Tian-yue, et al.
Publicado: (2023)

Role of TNFSF15 variants in oral cancer development and clinicopathologic characteristics
por: Lu, Hsueh‐Ju, et al.
Publicado: (2022)

TIMP-3 as a therapeutic target for cancer
por: Su, Chun-Wen, et al.
Publicado: (2019)

The impact of FOXP3 polymorphisms on oral cancer progression and clinicopathological characteristics
por: Chen, Ping-Ju, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_booqiq8m7motle20ci2nttqeil